Scandinavian Real Heart AB (Publ) (STO:HEART)

Sweden flag Sweden · Delayed Price · Currency is SEK
13.75
+0.25 (1.85%)
Apr 14, 2026, 5:20 PM CET
Market Cap116.84M +274.2%
Revenue (ttm)153.10K +7,832.5%
Net Income-35.50M
EPS-7.10
Shares Out8.50M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,239
Average Volume15,935
Open13.50
Previous Close13.50
Day's Range13.20 - 13.85
52-Week Range12.10 - 30.00
Beta0.97
RSI52.69
Earnings DateMay 13, 2026

About STO:HEART

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden. [Read more]

Sector Healthcare
Founded 1999
Employees 15
Stock Exchange Nasdaq Stockholm
Ticker Symbol HEART
Full Company Profile

Financial Performance

In 2025, STO:HEART's revenue was 153,098, an increase of 7832.54% compared to the previous year's 1,930. Losses were -35.50 million, 3.34% more than in 2024.

Financial Statements